Novo Nordisk has been providing women’s hormone therapy products worldwide for more than 25 years. We manufacture and sell a local vaginal estrogen therapy product called Vagifem, which has been available in the U.S. since 1999. Vagifem 10mcg is the lowest vaginal estrogen commercially available.
Indications and Usage:
Vagifem® (estradiol vaginal tablets) is used after menopause to treat menopausal changes in and around the vagina.
Do not start using Vagifem® if you currently have or have had certain cancers. Estrogens may increase the chances of getting certain types of cancers, including cancer of the breast or uterus. Also, do not start using Vagifem® if you have unusual vaginal bleeding, had a stroke or heart attack, currently have or have had blood clots, currently have or have had liver problems, have been diagnosed with a bleeding disorder, are allergic to Vagifem® or any of its ingredients, or think you may be pregnant.
Vagifem® is only used in the vagina; however, the risks associated with oral estrogens should be taken into account.
The most commonly reported side effects of Vagifem® included: headache, breast pain, irregular vaginal bleeding or spotting, stomach/abdominal cramps, bloating, nausea and vomiting, hair loss, fluid retention, and vaginal yeast infection.
Estrogens should be used at the lowest dose possible for your treatment only as long as needed.
Please click here (PDF) for Vagifem® Prescribing Information.
Vagifem® is a prescription medication.
Talk to your doctor to see if Vagifem® is right for you.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch , or call 1-800-FDA-1088.
Novo Nordisk provides patient assistance for those who qualify. Please call 1-866-310-7549 to learn more about Novo Nordisk assistance programs.